396 related articles for article (PubMed ID: 17433041)
21. Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
Boyd AS; Sanyal S; Abraham JL
J Am Acad Dermatol; 2010 Feb; 62(2):337-42. PubMed ID: 19939504
[TBL] [Abstract][Full Text] [Related]
22. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
Wiginton CD; Kelly B; Oto A; Jesse M; Aristimuno P; Ernst R; Chaljub G
AJR Am J Roentgenol; 2008 Apr; 190(4):1060-8. PubMed ID: 18356456
[TBL] [Abstract][Full Text] [Related]
23. [Nephrogenic systemic fibrosis and gadolinium-based contrast media].
Andréjak M; Thuillier D; Lok C; Gras-Champel V
Therapie; 2007; 62(2):169-72. PubMed ID: 17582319
[TBL] [Abstract][Full Text] [Related]
24. Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review.
Idée JM; Port M; Medina C; Lancelot E; Fayoux E; Ballet S; Corot C
Toxicology; 2008 Jun; 248(2-3):77-88. PubMed ID: 18440117
[TBL] [Abstract][Full Text] [Related]
25. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
Hamilton-Persaud K; Ezell LD; Macklin JG
Nephrol Nurs J; 2007; 34(3):283-7; quiz 288. PubMed ID: 17644872
[TBL] [Abstract][Full Text] [Related]
26. Nephrogenic systemic fibrosis: report of an additional case with granulomatous inflammation.
Wilford C; Fine JD; Boyd AS; Sanyal S; Abraham JL; Kantrow SM
Am J Dermatopathol; 2010 Feb; 32(1):71-5. PubMed ID: 19940755
[TBL] [Abstract][Full Text] [Related]
27. Nephrogenic systemic fibrosis: clinical spectrum of disease.
Mayr M; Burkhalter F; Bongartz G
J Magn Reson Imaging; 2009 Dec; 30(6):1289-97. PubMed ID: 19937929
[TBL] [Abstract][Full Text] [Related]
28. Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: a primer for radiologists.
Prasad SR; Jagirdar J
J Comput Assist Tomogr; 2008; 32(1):1-3. PubMed ID: 18303280
[TBL] [Abstract][Full Text] [Related]
29. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis.
Abraham JL; Thakral C; Skov L; Rossen K; Marckmann P
Br J Dermatol; 2008 Feb; 158(2):273-80. PubMed ID: 18067485
[TBL] [Abstract][Full Text] [Related]
30. Nephrogenic systemic fibrosis: relationship to gadolinium and response to photopheresis.
Richmond H; Zwerner J; Kim Y; Fiorentino D
Arch Dermatol; 2007 Aug; 143(8):1025-30. PubMed ID: 17709661
[TBL] [Abstract][Full Text] [Related]
31. Nephrogenic systemic fibrosis: more questions and some answers.
Morcos SK; Thomsen HS
Nephron Clin Pract; 2008; 110(1):c24-31; discussion c32. PubMed ID: 18688172
[TBL] [Abstract][Full Text] [Related]
32. [Nephrogenic systemic fibrosis].
Cavallini L; Abaterusso C; Bedogna V; Pertica N; Loschiavo C; Lupo A
G Ital Nefrol; 2008; 25(1):14-20. PubMed ID: 18264914
[TBL] [Abstract][Full Text] [Related]
33. [Nephrogenic systemic fibrosis possibly caused by gadolinium-containing contrast agent].
van der Meij N; Keur I; van Lienden KP; Scheepstra CG; Bos JD
Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2898-903. PubMed ID: 18257437
[TBL] [Abstract][Full Text] [Related]
34. Gadolinium-associated nephrogenic systemic fibrosis.
Schlaudecker JD; Bernheisel CR
Am Fam Physician; 2009 Oct; 80(7):711-4. PubMed ID: 19817341
[TBL] [Abstract][Full Text] [Related]
35. The impact of NSF on the care of patients with kidney disease.
Abu-Alfa A
J Am Coll Radiol; 2008 Jan; 5(1):45-52. PubMed ID: 18180009
[TBL] [Abstract][Full Text] [Related]
36. Nephrogenic systemic fibrosis, in patients with end-stage kidney disease on dialysis, in the greater Auckland region, from 2000-2006.
Kendrick-Jones JC; Voss DM; De Zoysa JR
Nephrology (Carlton); 2011 Feb; 16(2):243-8. PubMed ID: 21272139
[TBL] [Abstract][Full Text] [Related]
37. [Nephrogenic systemic fibrosis after application of gadolinium-based contrast agents--a status paper].
Heinrich M; Uder M
Rofo; 2007 Jun; 179(6):613-7. PubMed ID: 17497597
[TBL] [Abstract][Full Text] [Related]
38. Gadolinium-induced nephrogenic systemic fibrosis is associated with insoluble Gd deposits in tissues: in vivo transmetallation confirmed by microanalysis.
Thakral C; Abraham JL
J Cutan Pathol; 2009 Dec; 36(12):1244-54. PubMed ID: 19602073
[TBL] [Abstract][Full Text] [Related]
39. Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure.
Othersen JB; Maize JC; Woolson RF; Budisavljevic MN
Nephrol Dial Transplant; 2007 Nov; 22(11):3179-85. PubMed ID: 17890246
[TBL] [Abstract][Full Text] [Related]
40. Clinical and histological findings in nephrogenic systemic fibrosis.
Cowper SE; Rabach M; Girardi M
Eur J Radiol; 2008 May; 66(2):191-9. PubMed ID: 18325705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
